BackJohnson Chemical Pharmaceutical Works , Ltd. Overview
Johnson Chemical Pharmaceutical Works Co., Ltd.

Johnson Chemical Pharmaceutical Works , Ltd. Return on Equity

Latest ROE for Johnson Chemical Pharmaceutical Works , Ltd.: 1.21% — see history and peer comparisons.

Get informed when a big investor buys or sells

+ Follow

ROE

1.21%

Return on Equity

1.21%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

Johnson Chemical Pharmaceutical Works , Ltd. (4747.TWO) FAQ

Johnson Chemical Pharmaceutical Works , Ltd.'s return on equity stands at 1.21%. That is below the sector sector average of 11.3%. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Johnson Chemical Pharmaceutical Works , Ltd. sits lower the its sector benchmark (11.3%) with a ROE of 1.21%. That is roughly 89.3% below the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.

A ROE of 1.21% for Johnson Chemical Pharmaceutical Works , Ltd. means each unit of related capital or sales is generating that return rate. Higher is usually better for profitability metrics, but extremely high figures can reflect one-time items or thin equity bases. Review several years of data on this page before extrapolating.

The history chart shows how Johnson Chemical Pharmaceutical Works , Ltd.'s ROE evolved across reporting periods, while the comparison chart places 4747.TWO next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.